Analysis of different HER-2 mutations in breast cancer progression and drug resistance
about
Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancerGeneration, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants.Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.Experimental study on the clinical effects of Xiaoru Sanjie Jiaonang on mammary glands hyperplasia and ki-67.Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.
P2860
Q36650443-ECE3CE45-E0B2-4982-833C-F33EF3C81228Q37447938-0E4A2317-C58F-4853-BED0-3DC4F5B3D57EQ37644205-63190637-70CA-408D-9CDD-09FE4F25606EQ48042475-8A463120-D58C-4BB1-A297-582A8641A4D8Q48205560-F4D8C42C-257C-49FE-AE2E-1CD57163E941Q52720152-CE281821-71E7-435C-8C5C-B684A32AF864Q55309854-1416728F-874B-44B5-BDCC-B5099889CF2B
P2860
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@ast
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@en
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@nl
type
label
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@ast
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@en
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@nl
prefLabel
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@ast
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@en
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@nl
P2093
P2860
P921
P356
P1476
Analysis of different HER-2 mutations in breast cancer progression and drug resistance
@en
P2093
Wenwen Zhang
Xiaoxiang Guan
P2860
P304
P356
10.1111/JCMM.12662
P407
P5008
P577
2015-12-01T00:00:00Z